Fresenius Medical Care Midwest Appleton Ave is a medicare approved dialysis facility center in Milwaukee, Wisconsin and it has 19 dialysis stations. It is located in Milwaukee county at 7793 W Appleton Ave, Milwaukee, WI, 53222. You can reach out to the office of Fresenius Medical Care Midwest Appleton Ave at (414) 464-0820. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Midwest Appleton Ave has the following ownership type - Profit. It was first certified by medicare in December, 2006. The medicare id for this facility is 522571 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care Midwest Appleton Ave |
|---|---|
| Location | 7793 W Appleton Ave, Milwaukee, Wisconsin |
| No. of Dialysis Stations | 19 |
| Medicare ID | 522571 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 7793 W Appleton Ave, Milwaukee, Wisconsin, 53222 | |
| (414) 464-0820 | |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
| NPI Number | 1043556822 |
| Organization Name | Fresenius Medical Care Midwest Appleton Avenue |
| Doing Business As | Fresenius Medical Care Midwest Dialysis, Llc |
| Address | 7793 W Appleton Ave Milwaukee, Wisconsin, 53222 |
| Phone Number | (414) 393-9810 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
| NPI Number | 1306926910 |
| Organization Name | Midwest Dialysis Center-appleton Ave Branch |
| Doing Business As | Midwest Dialysis Center, Inc. |
| Address | 7793 W Appleton Ave Milwaukee, Wisconsin, 53222 |
| Phone Number | (414) 762-2020 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 40% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 16% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 44% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 34% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 32% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 34% | 14% |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 48% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 23% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 29% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 39% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 30% | 12% |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 64% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 36% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 36% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 33% | 12% |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 42 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 97 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 911 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Midwest Appleton Ave with elevated calcium levels.
| Patients with hypercalcemia | 101 |
| Hypercalcemia patient months | 958 |
| Patients with Serumphosphor | 107 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 33 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 13 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 68 |
| Patient months included in arterial venous fistula and catheter summaries | 535 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 68 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 14 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 79 |
| Hospitalization Rate in facility | 212.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 348.7 |
| Hospitalization Rate: Lower Confidence Limit | 132.9 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care Midwest Appleton Ave were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 27.3 |
| Readmission Rate: Lower Confidence Limit | 12.7 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care Midwest Appleton Ave get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .17 (Better than Expected) |
| SIR: Upper Confidence Limit | .85 |
| SIR: Lower Confidence Limit | .01 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Midwest Appleton Ave's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 70 |
| Transfusion Rate in facility | 34.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 89.6 |
| Transfusion Rate: Lower Confidence Limit | 15.2 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care Midwest Appleton Ave lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 409 |
| Mortality Rate in facility | 16 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.5 |
| Mortality Rate: Lower Confidence Limit | 11.6 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago
Davita - Wisconsin Ave Location: 3801 W Wisconsin Ave, Milwaukee, Wisconsin, 53208 Phone: (414) 937-8240 |
Fresenius Medical Care Midwest South Location: 3267 S 16th St Suite 203, Milwaukee, Wisconsin, 53215 Phone: (414) 672-8230 |
Davita - Rivercenter Dr Location: 117 N Jefferson St, Milwaukee, Wisconsin, 53202 Phone: (414) 225-3740 |
FMC Dialysis - Milwaukee Location: 161 W Wisconsin Ave, Milwaukee, Wisconsin, 53203 Phone: (414) 224-7666 |
Fresenius Medical Care Midwest Dialysis, Llc Location: 4021 N 52nd St, Milwaukee, Wisconsin, 53216 Phone: (414) 873-3600 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone RTSM (randomisation and trial supply management) service.
According to new research from the Centre for Market and Public Organisation (CMPO), based at the University of Bristol, the explanation lies in regional differences in the gap between wages in the private and public sectors.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
CyMedica Orthopedics, Inc. today announced that it has received a CE (Conformité Européenne) Mark for its QB1 Muscle Activation System. The product received its FDA 510(k) clearance in April 2015, and has since enjoyed a tremendous reception from orthopedic surgeons and knee patients across the United States.
› Verified 4 days ago